Patent intelligence · US
US 8697130
Non-irritating benzoyl peroxide
Non-irritating benzoyl peroxide
Patent details — US 8697130
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 15, 2014
- Expiration
- Apr 10, 2034
- Applicant
- Essential Ingredients, Inc.
- Claims
- 14
- CPC classes
- A61K, A61K2800/412, A61K2800/75, A61K8/0241
Quick answer
US 8697130 (Non-irritating benzoyl peroxide) is held by Essential Ingredients, Inc.. Status: granted. Granted Apr 15, 2014. Expires Apr 10, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Essential Ingredients, Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K2800/412, A61K2800/75, A61K8/0241, A61K8/042, A61K8/38
More from Essential Ingredients, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 8697130?
US 8697130 (Non-irritating benzoyl peroxide) is held by Essential Ingredients, Inc.. Status: granted. Granted Apr 15, 2014. Expires Apr 10, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8697130?
Essential Ingredients, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 8697130 expire?
Our index shows an expiration date of Apr 10, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.